Table 2 Number and location of main pulmonary CT manifestations in the 108 pulmonary segments of BCG infection (n = 18).
From: Imaging characteristics of pulmonary BCG/TB infection in patients with chronic granulomatous disease
RUL (%) | RML (%) | RLL (%) | LUL (%) | Lingula (%) | LLL (%) | N (%) | |
|---|---|---|---|---|---|---|---|
Consolidation | 6 (5.56) | 2 (1.85) | 1 (0.93) | 5 (4.63) | 1 (0.93) | 1 (0.93) | 16 (14.81) |
Nodules | 3 (2.78) | 3 (2.78) | 7 (7.41) | 2 (1.85) | 4 (3.70) | 9 (8.33) | 28 (25.93) |
Cavity | 2 (1.85) | 0 | 0 | 0 | 0 | 0 | 2 (1.85) |
Ground-glass opacity | 9 (8.33) | 7 (7.41) | 8 (44.44) | 9 (8.33) | 7 (7.41) | 10 (9.26) | 50 (46.30) |
Tree-in bud opacities | 1 (0.93) | 2 (1.85) | 0 | 0 | 0 | 0 | 3 (2.78) |
Bronchiectasis | 3 (2.78) | 0 | 1 (0.93) | 2 (1.85) | 0 | 1 (0.93) | 7 (6.48) |
Emphysema | 6 (5.56) | 2 (1.85) | 5 (4.63) | 4 (3.70) | 2 (1.85) | 6 (5.56) | 25 (23.15) |
Pulmonary scarring | 10 (9.26) | 5 (4.63) | 7 (7.41) | 6 (5.56) | 5 (4.63) | 7 (7.41) | 40 (37.04) |
Mass | 3 (2.78) | 1 (0.93) | 0 | 0 | 2 (1.85) | 2 (1.85) | 8 (7.41) |
Interlobular septal thickening | 1 (0.93) | 2 (1.85) | 3 (2.78) | 0 | 0 | 3 (2.78) | 9 (8.33) |
Pulmonary calcification | 3 (2.78) | 3 (2.78) | 4 (3.70) | 3 (2.78) | 2 (1.85) | 5 (4.63) | 20 (18.52) |
